![](https://www.diabetesnews.com/wp-content/uploads/2013/05/Pill_by_sgwizdak-150x150.jpg)
The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.
Read more
The fixed combination of the drugs saxagliptin and metformin (Komboglyze®) has been approved in Germany since November 2011 for the treatment of type 2 diabetes mellitus.
Read more